PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Drug ReportsNitroglycerin
Nitroglycerin
Nitro-dur, Nitroglycerin, Nitrolingual Pumpspray, Nitromist, Nitrostat, Rectiv (nitroglycerin) is a small molecule pharmaceutical. Nitroglycerin was first approved as Nitroglycerin on 1982-01-01. It is used to treat angina pectoris, diffuse esophageal spasm, eclampsia, fissure in ano, and heart failure amongst others in the USA.
Download report
Favorite
Searched
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Plot placeholder
Mock data
Subscribe for the real data
Commercial
Therapeutic Areas
Therapeutic Area
MeSH
digestive system diseasesD004066
respiratory tract diseasesD012140
urogenital diseasesD000091642
cardiovascular diseasesD002318
signs and symptoms pathological conditionsD013568
Trade Name
FDA
EMA
Nitro-dur, Nitroglycerin, Nitrolingual pumpspray, Nitromist, Nitrostat, Rectiv (discontinued: Gonitro, Minitran, Nitro, Nitro-bid, Nitroglycerin, Nitrol, Nitrolingual pumpspray, Nitrostat, Transderm-nitro, Tridil)
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Nitroglycerin
Tradename
Company
Number
Date
Products
RECTIVAbbVieN-021359 RX2011-06-21
1 products, RLD, RS
NITROGLYCERIN IN DEXTROSE 5%BaxterN-019970 RX1989-12-29
3 products, RLD, RS
NITROMISTEvus Health SolutionsN-021780 RX2006-11-02
1 products, RLD, RS
NITROLINGUAL PUMPSPRAYPohl-BoskampN-018705 RX1997-01-10
1 products, RLD, RS
NITRO-DURUSpharmaN-020145 RX1995-04-04
6 products, RLD, RS
NITROSTATViatrisN-021134 RX2000-05-01
3 products, RLD, RS
Show 10 discontinued
Labels
FDA
EMA
Brand Name
Status
Last Update
basic dental emergency kitunapproved drug other2024-10-03
deluxe dental emergency kitunapproved drug other2024-10-03
gonitroNew Drug Application2018-06-20
minitranExport only2025-01-15
nitro-bidANDA2024-09-04
nitro-durNew Drug Application2023-05-30
nitro-timeunapproved drug other2018-10-09
nitroglycerinANDA2025-09-02
nitroglycerin in dextroseNew Drug Application2022-12-09
nitroglycerin in dextroseNew Drug Application2016-08-22
Show 9 more
Agency Specific
FDA
EMA
No data
Patent Expiration
Patent
Expires
Flag
FDA Information
Nitroglycerin, Gonitro, Pohl Boskamp
91015922032-03-11DP
Nitroglycerin, Nitrolingual, Pohl Boskamp
78720492029-03-12DPU-2223
ATC Codes
No data
HCPCS
No data
Clinical
Clinical Trials
5425 clinical trials
View more details
Plot placeholder
Mock data
Subscribe for the real data
Indications Phases 4
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
LymphomaD008223C85.937779119514541249
LeukemiaD007938C952855041361843859
Breast neoplasmsD001943EFO_0003869C501103611761344638
Multiple myelomaD009101C90.020036065824567
Non-hodgkin lymphomaD008228C85.918331568321499
Plasma cell neoplasmsD05421915527855718442
Precursor cell lymphoblastic leukemia-lymphomaD054198C91.0143241671720425
Lymphoid leukemiaD007945C91132227771716415
B-cell lymphomaD01639316220933312344
Large b-cell lymphoma diffuseD016403C83.312020448311329
Show 199 more
Indications Phases 3
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
NeoplasmsD009369C802311912624394
Myeloid leukemia acuteD015470C92.0971543112258
Myeloid leukemiaD007951C92761372611218
MelanomaD008545878366151
Hematologic neoplasmsD019337598678136
Ovarian neoplasmsD010051EFO_0003893C566872102123
Myeloproliferative disordersD009196D47.13482411120
NeuroblastomaD009447EFO_00006214946227116
CarcinomaD002277C80.0665965114
Bcr-abl positive chronic myelogenous leukemiaD015464EFO_0000340268786112
Show 272 more
Indications Phases 2
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Liver neoplasmsD008113EFO_1001513C22.02618238
Mycosis fungoidesD009182C84.01219937
T-cell lymphoma cutaneousD016410C84.A1319836
MycosesD009181B35-B491018530
Skin neoplasmsD012878EFO_0004198C441119328
Hepatocellular carcinomaD006528C22.01612122
MesotheliomaD008654C451712222
Myeloid leukemia accelerated phaseD015465517121
Adult t-cell leukemia-lymphomaD015459C91.5913221
Prolymphocytic leukemiaD015463515120
Show 291 more
Indications Phases 1
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Migraine disordersD008881EFO_0003821G43189
PinealomaD01087155
Muscular diseasesD009135EFO_0002970G72.944
Adrenocortical carcinomaD01826833
HepatectomyD006498123
Papillary thyroid cancerD00007727322
Colonic polypsD003111K63.522
Barrett esophagusD001471EFO_0000280K22.722
Neuroepithelial neoplasmsD01830222
Optic nerve gliomaD02033922
Show 66 more
Indications Without Phase
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
AtherosclerosisD050197EFO_0003914I25.166
HeadacheD006261R5144
Acute kidney injuryD058186N1744
AnesthesiaD00075833
Microvascular anginaD01756633
Coronary circulationD00332633
Pathologic constrictionD00325133
Migraine with auraD020325EFO_0005295G43.133
Hemoglobin sc diseaseD006450EFO_1001797D57.222
DysmenorrheaD004412N94.622
Show 162 more
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common nameNitroglycerin
INN
Description
Nitroglycerin is a nitroglycerol that is glycerol in which the hydrogen atoms of all three hydroxy groups are replaced by nitro groups. It acts as a prodrug, releasing nitric oxide to open blood vessels and so alleviate heart pain. It has a role as a vasodilator agent, a nitric oxide donor, an explosive, a prodrug, a tocolytic agent, a muscle relaxant and a xenobiotic.
Classification
Small molecule
Drug class
Image (chem structure or protein)Loading
Structure (InChI/SMILES or Protein Sequence)
O=[N+]([O-])OCC(CO[N+](=O)[O-])O[N+](=O)[O-]
Identifiers
PDB
CAS-ID55-63-0
RxCUI
ChEMBL IDCHEMBL730
ChEBI ID28787
PubChem CID4510
DrugBankDB00727
UNII ID
Target
No data
Variants
No data
Financial
Revenue by drug
$
£
No data
Estimated US medical usage
Nitroglycerin
Total medical expenditures per year (USD, in millions)
Plot placeholder
Mock data
Subscribe for the real data
Number of persons purchased
Plot placeholder
Mock data
Subscribe for the real data
Number of purchases
Plot placeholder
Mock data
Subscribe for the real data
Refill frequency
Plot placeholder
Mock data
Subscribe for the real data
Price per prescription (USD)
Plot placeholder
Mock data
Subscribe for the real data
Tabular view
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Plot placeholder
Mock data
Subscribe for the real data
Additional graphs summarizing 25,590 documents
View more details
Safety
Black-box Warning
Black-box warning for: Nitro-dur, Nitroglycerin transdermal infusion system
Adverse Events
Top Adverse Reactions
Plot placeholder
Mock data
Subscribe for the real data
10,550 adverse events reported
View more details
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use